Call for Applicants
Australian scientists are recognized for world class innovation, but historically the challenge has been translating that work into commercial success. The work of Australian of the Year, Professor Ian Frazer, is a success that should be repeated.
“Australian science is rich in ideas and innovation, but the best medical discoveries will not help one person unless we understand the commercialisation process and can navigate the journey from compound to life-changing or life-saving medicine.”
Professor Ian Frazer, 2006 Australian of the Year
Now, Merck Sharp & Dohme* and Advance† have formed a partnership to open new doors for Australian scientists with the Advancing BioBusiness Award. The Award will provide the next generation of leaders in Australian biotechnology with access to leading institutions, companies and individuals in the
The two recipients of the Advancing
The Award will provide business class air travel and accommodation for the recipients to attend
The Award recipients will be required to share their experience of the program on return to
Applications are invited from Australian-based scientists who have completed their post doctoral training and are conducting research in an institution or biotech company in
The applications will be assessed by a panel of experts including Dr Graeme
HOW TO ENTER
Please click on the following link to download an application form (in pdf format), which also contains full terms and conditions of the Advancing
The closing date for applications is
*Merck Sharp & Dohme (Australia) Pty Limited is the Australian subsidiary of the global research-based pharmaceutical company Merck & Co., Inc., Whitehouse Station, N.J., U.S.A. Merck Sharp & Dohme (Australia) Pty Limited 54-68 Ferndell Street South Granville NSW 2142.
†Advance builds links between the one million Australians in our diaspora making their mark in boardrooms, science laboratories, institutions and communities worldwide (http//www.advance.org).